Skip to content
Screener

Puma Biotechnology PBYI Q4 2025 Annual earnings

Reported February 26, 2026 · After market close

Revenue$59.9MMiss by $8.7M
EPS$0.29Beat by $0.05
Revenue estimate$68.6M
EPS estimate$0.24

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$57.5M
EPS estimate$0.11

FAQ

When did Puma Biotechnology report Q4 2025 earnings?
Puma Biotechnology (PBYI) reported Q4 2025 earnings on February 26, 2026 after market close.
What were Puma Biotechnology's Q4 2025 revenue and EPS?
Puma Biotechnology reported revenue of $59.9M and eps of $0.29 for Q4 2025.
Did Puma Biotechnology beat estimates in Q4 2025?
Revenue missed the consensus estimate of $68.6M by $8.7M. EPS beat the consensus estimate of $0.24 by $0.05.
How did Puma Biotechnology's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 1.4% from $59.1M a year earlier and eps declined 32.6% from $0.43.
Where can I find Puma Biotechnology's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001437749-26-005869) and the 10-K periodic report (0001437749-26-005891) directly on SEC EDGAR. The filing index links above go to sec.gov.